TCL Archive New Seer Report Says Five Year Relative Survival At 49 Per Cent Over all, 50 Per Cent For White November 30, 1984
TCL Archive FDA Plans to Discuss the Negative Trial of AstraZeneca’s Drug Iressa With the Oncologic Drugs Advisory Committee in March. January 21, 2005
